Fei Fei, M.D.

(877) 460-4673
Fei Fei, M.D.
Pathologist
Clinical Expertise
  • Molecular Pathology
Other Languages Spoken
Mandarin
Academic Appointments
  • Assistant Clinical Professor, Department of Pathology
Clinical Teams
Pathology

Fei Fei, M.D., is an Assistant Clinical Professor in the Department of Pathology, specializing in molecular pathology. She earned her medical degree from Southeast University in China and completed her anatomic and clinical pathology residency at the University of Alabama at Birmingham. Dr. Fei then pursued fellowship training in hematopathology and molecular genetic pathology at Stanford University.
Board-certified in anatomic and clinical pathology, hematopathology, and molecular genetic pathology, Dr. Fei is particularly interested in investigating the molecular mechanisms underlying disease pathogenesis, an interest that drives her research efforts. She has authored numerous publications and has been invited to present her work at several international conferences.

Location

Education & Experience

Board Certification

  • 2023 - Present, Molecular Genetic Pathology, American Board of Pathology
  • 2022 - Present, Hematopathology, American Board of Pathology
  • 2021 - Present, Anatomic and Clinical Pathology, American Board of Pathology

Degrees

  • 2007, M.D., Ulm University, Ulm, Germany

Fellowship

  • 2023, Fellowship, Molecular Genetic Pathology, Stanford University, Stanford, California
  • 2022, Fellowship, Hematopathology, Stanford University, Stanford, California
  • 2015, Postdoctoral Fellowship, Hematology/Oncology, Children’s Hospital Los Angeles, University of Southern California, Los Angeles, California
  • 2008, Postdoctoral Fellowship, Hematology/Oncology, Ulm University, Ulm, Germany

Residency

  • 2021, Anatomic and Clinical Pathology, University of Alabama, Birmingham, Alabama
  • 2006, Hematology, Zhong Da Hospital, Southeast University, Nanjing, China

Professional Experience

  • 2023–present, Assistant Clinical Professor, Department of Pathology, City of Hope, Duarte, California

Awards & Memberships

Awards

  • 2022, Pathology Trainee Mentored Award, Stanford University
  • 2018, Adam Grant (Resident research grant), The University of Alabama at Birmingham

Memberships

  • 2018, United States and Canadian Academy of Pathology
  • 2017, College of American Pathologists
  • 2017, American Society for Clinical Pathology
  • 2012, American Association for Cancer Research

Publications

  • Fei F, Telatar M, Tomasian V, Chang L, Gust M, Yew H, DyerT, Danilova 0, Arias­Stella J 3rd, Pillai R, Aldoss I, Stewart FM, Becker PS, Pullarkat V, Marcucci G, Afkhami M. Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies. Int J Mol Sci. 2025 Jan 7;26(2):435. doi:10.3390/ijms26020435. PMID: 39859151.
  • Fei F, Jariwala A, Pullarkat S, Loo E, Liu Y, Tizro P, Ali H, Otoukesh S, Amanam I, Artz A, Ally F, Telatar M, Nakamura R, Marcucci G, Afkhami M. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Int J Mol Sci. 2024 Sep 23;25(18):10214. doi:10.3390/ijms251810214. PMID: 39337700
  • Soma L, Crisan L, Reid J, Lee W, Song J, Afkhami M, Shouse G, Fei F, Danilova 0, Pillai R, Zain J, Querfeld C. Epstein-Barr virus-positive, primary cutaneous marginal zone lymphoma, with transformation: Case report and review of the literature. Am J Clin Pathol. 2024 Sep 17:aqae124. doi: 10.1093/ajcp/aqae124. Epub ahead of print. PMID: 39290045.
  • Fei F, Brar N, Herring MB, Menke JR, Oak J, Fernandez-Pol S. Quantification of the median fluorescence intensity of CD3 and CD4 in mycosis fungoides/Sezary syndrome versus non-neoplastic control cases in peripheral blood. J Hematop. 2024 Aug 2. doi: 10.1007/s12308-024-00599-2. Online ahead of print. PMID: 39093388
  • Fei F, Caporale C, Chang L, Fortini BK, Ali H, Bell D, Stein A, Marcucci G, Telatar M, Afkhami M. BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis Experience. Int J Mol Sci. 2024 May 9;25(10):5183. doi: 10.3390/ijms25105183. PMID: 38791222; PMCID: PMC11121641.
  • Fei F, Kunder CA, Ho C, Zehnder JL, Tomasello G, Fung E, Suarez CJ. Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: A single-institution experience. Am J Clin Pathol. 2024 Apr 3; 161 (4):329-341. doi: 10.1093/ajcp/aqad148. PMID: 38001052.